NCT05805033 Peri-Implant Soft Tissue Integration in Humans: Influence of Material
| NCT ID | NCT05805033 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Liege |
| Condition | Healthy Subjects |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-09-22 |
| Primary Completion | 2024-06-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-09-22 with a primary completion date of 2024-06-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the mucointegration of 2 types of surface roughness of zirconia abutments with titanium. The surface roughness will be machined and ultra-polished.
Eligibility Criteria
Inclusion Criteria: * Participants have to voluntarily sign the informed consent form before any study related action * Patients aged 18 or over * Patients with one or more missing teeth in the maxillary or mandible area, seeking implant therapy * Men/women * Patients in good systemic health (ASA I/ II) and no contraindication for oral surgical interventions * Patients requiring a replacement of missing teeth; the tooth at the implant site(s) must have been extracted or lost at least 12 weeks before the date of implantation * At least 3 mm of fibrous mucosa in the bucco-lingual dimension * Full mouth plaque score (FMPI) lower than or equal to 25% * At least a diameter of 4 mm for the implant (regular diameter) Exclusion Criteria: * Autoimmune disease requiring medical treatment * Medical conditions requiring prolonged use of steroids * Use of Bisphosphonates intravenously or more than 3 years of oral use * Infection (local or systemic) - patients with gingivitis or active local infection will undergo a medical treatment prior to the entrance to the study, and each individual will be evaluated for suitability; in case of a systemic infection, the evaluation will be based on medical anamneses, and if necessary, a patient will be referred to relevant medical tests * Current pregnancy or breastfeeding women * Alcoholism or chronical drug abuse * Immunocompromised patients * Uncontrolled diabetes * Smokers * Prisoners * Implant's diameter under 4 mm (narrow implant) * Conditions or circumstances, in the opinion of the investigator, which would prevent completion of the study or interference with analysis of study results, such as history of non-compliance, or unreliability
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05805033 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Subjects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05805033 currently recruiting?
Yes, NCT05805033 is actively recruiting participants. Contact the research team at clementine.canuel@hotmail.fr for enrollment information.
Where is the NCT05805033 trial being conducted?
This trial is being conducted at Liège, Belgium.
Who is sponsoring the NCT05805033 clinical trial?
NCT05805033 is sponsored by Centre Hospitalier Universitaire de Liege. The trial plans to enroll 40 participants.